Copyright Reports & Markets. All rights reserved.

Global Inflammatory Bowel Disease Therapeutics Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Inflammatory Bowel Disease Therapeutics

      • 1.1 Definition of Inflammatory Bowel Disease Therapeutics
      • 1.2 Inflammatory Bowel Disease Therapeutics Segment by Type
        • 1.2.1 Global Inflammatory Bowel Disease Therapeutics Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Anti-inflammatory Biologics
        • 1.2.3 Non-Steroidal Anti-inflammatory drugs (NSAIDs)
        • 1.2.4 Corticosteroids
      • 1.3 Inflammatory Bowel Disease Therapeutics Segment by Applications
        • 1.3.1 Global Inflammatory Bowel Disease Therapeutics Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Solid
        • 1.3.3 Liquid
      • 1.4 Global Inflammatory Bowel Disease Therapeutics Overall Market
        • 1.4.1 Global Inflammatory Bowel Disease Therapeutics Revenue (2014-2025)
        • 1.4.2 Global Inflammatory Bowel Disease Therapeutics Production (2014-2025)
        • 1.4.3 North America Inflammatory Bowel Disease Therapeutics Status and Prospect (2014-2025)
        • 1.4.4 Europe Inflammatory Bowel Disease Therapeutics Status and Prospect (2014-2025)
        • 1.4.5 China Inflammatory Bowel Disease Therapeutics Status and Prospect (2014-2025)
        • 1.4.6 Japan Inflammatory Bowel Disease Therapeutics Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Inflammatory Bowel Disease Therapeutics Status and Prospect (2014-2025)
        • 1.4.8 India Inflammatory Bowel Disease Therapeutics Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Inflammatory Bowel Disease Therapeutics
      • 2.3 Manufacturing Process Analysis of Inflammatory Bowel Disease Therapeutics
      • 2.4 Industry Chain Structure of Inflammatory Bowel Disease Therapeutics

      3 Development and Manufacturing Plants Analysis of Inflammatory Bowel Disease Therapeutics

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Inflammatory Bowel Disease Therapeutics Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Inflammatory Bowel Disease Therapeutics
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Inflammatory Bowel Disease Therapeutics Production and Capacity Analysis
      • 4.2 Inflammatory Bowel Disease Therapeutics Revenue Analysis
      • 4.3 Inflammatory Bowel Disease Therapeutics Price Analysis
      • 4.4 Market Concentration Degree

      5 Inflammatory Bowel Disease Therapeutics Regional Market Analysis

      • 5.1 Inflammatory Bowel Disease Therapeutics Production by Regions
        • 5.1.1 Global Inflammatory Bowel Disease Therapeutics Production by Regions
        • 5.1.2 Global Inflammatory Bowel Disease Therapeutics Revenue by Regions
      • 5.2 Inflammatory Bowel Disease Therapeutics Consumption by Regions
      • 5.3 North America Inflammatory Bowel Disease Therapeutics Market Analysis
        • 5.3.1 North America Inflammatory Bowel Disease Therapeutics Production
        • 5.3.2 North America Inflammatory Bowel Disease Therapeutics Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Inflammatory Bowel Disease Therapeutics Import and Export
      • 5.4 Europe Inflammatory Bowel Disease Therapeutics Market Analysis
        • 5.4.1 Europe Inflammatory Bowel Disease Therapeutics Production
        • 5.4.2 Europe Inflammatory Bowel Disease Therapeutics Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Inflammatory Bowel Disease Therapeutics Import and Export
      • 5.5 China Inflammatory Bowel Disease Therapeutics Market Analysis
        • 5.5.1 China Inflammatory Bowel Disease Therapeutics Production
        • 5.5.2 China Inflammatory Bowel Disease Therapeutics Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Inflammatory Bowel Disease Therapeutics Import and Export
      • 5.6 Japan Inflammatory Bowel Disease Therapeutics Market Analysis
        • 5.6.1 Japan Inflammatory Bowel Disease Therapeutics Production
        • 5.6.2 Japan Inflammatory Bowel Disease Therapeutics Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Inflammatory Bowel Disease Therapeutics Import and Export
      • 5.7 Southeast Asia Inflammatory Bowel Disease Therapeutics Market Analysis
        • 5.7.1 Southeast Asia Inflammatory Bowel Disease Therapeutics Production
        • 5.7.2 Southeast Asia Inflammatory Bowel Disease Therapeutics Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Inflammatory Bowel Disease Therapeutics Import and Export
      • 5.8 India Inflammatory Bowel Disease Therapeutics Market Analysis
        • 5.8.1 India Inflammatory Bowel Disease Therapeutics Production
        • 5.8.2 India Inflammatory Bowel Disease Therapeutics Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Inflammatory Bowel Disease Therapeutics Import and Export

      6 Inflammatory Bowel Disease Therapeutics Segment Market Analysis (by Type)

      • 6.1 Global Inflammatory Bowel Disease Therapeutics Production by Type
      • 6.2 Global Inflammatory Bowel Disease Therapeutics Revenue by Type
      • 6.3 Inflammatory Bowel Disease Therapeutics Price by Type

      7 Inflammatory Bowel Disease Therapeutics Segment Market Analysis (by Application)

      • 7.1 Global Inflammatory Bowel Disease Therapeutics Consumption by Application
      • 7.2 Global Inflammatory Bowel Disease Therapeutics Consumption Market Share by Application (2014-2019)

      8 Inflammatory Bowel Disease Therapeutics Major Manufacturers Analysis

      • 8.1 Abbvie
        • 8.1.1 Abbvie Inflammatory Bowel Disease Therapeutics Production Sites and Area Served
        • 8.1.2 Abbvie Product Introduction, Application and Specification
        • 8.1.3 Abbvie Inflammatory Bowel Disease Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Johnson & Johnson
        • 8.2.1 Johnson & Johnson Inflammatory Bowel Disease Therapeutics Production Sites and Area Served
        • 8.2.2 Johnson & Johnson Product Introduction, Application and Specification
        • 8.2.3 Johnson & Johnson Inflammatory Bowel Disease Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 GlaxoSmithKline
        • 8.3.1 GlaxoSmithKline Inflammatory Bowel Disease Therapeutics Production Sites and Area Served
        • 8.3.2 GlaxoSmithKline Product Introduction, Application and Specification
        • 8.3.3 GlaxoSmithKline Inflammatory Bowel Disease Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Merck
        • 8.4.1 Merck Inflammatory Bowel Disease Therapeutics Production Sites and Area Served
        • 8.4.2 Merck Product Introduction, Application and Specification
        • 8.4.3 Merck Inflammatory Bowel Disease Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Novartis
        • 8.5.1 Novartis Inflammatory Bowel Disease Therapeutics Production Sites and Area Served
        • 8.5.2 Novartis Product Introduction, Application and Specification
        • 8.5.3 Novartis Inflammatory Bowel Disease Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served

      9 Development Trend of Analysis of Inflammatory Bowel Disease Therapeutics Market

      • 9.1 Global Inflammatory Bowel Disease Therapeutics Market Trend Analysis
        • 9.1.1 Global Inflammatory Bowel Disease Therapeutics Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Inflammatory Bowel Disease Therapeutics Regional Market Trend
        • 9.2.1 North America Inflammatory Bowel Disease Therapeutics Forecast 2019-2025
        • 9.2.2 Europe Inflammatory Bowel Disease Therapeutics Forecast 2019-2025
        • 9.2.3 China Inflammatory Bowel Disease Therapeutics Forecast 2019-2025
        • 9.2.4 Japan Inflammatory Bowel Disease Therapeutics Forecast 2019-2025
        • 9.2.5 Southeast Asia Inflammatory Bowel Disease Therapeutics Forecast 2019-2025
        • 9.2.6 India Inflammatory Bowel Disease Therapeutics Forecast 2019-2025
      • 9.3 Inflammatory Bowel Disease Therapeutics Market Trend (Product Type)
      • 9.4 Inflammatory Bowel Disease Therapeutics Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Inflammatory Bowel Disease Therapeutics Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Inflammatory bowel disease (IBD) is a broad term used to describe disorders involving chronic inflammation of digestive tract. The disease is categorized by severe diarrhea, abdominal pain, fatigue, and weight loss.
        Increase in incidences of IBD and rise in adoption of anti-inflammatory drugs drive the market.  
        In addition, strong upcoming pipeline of IBD drugs also boosts the market growth.
        However, side effects of these drugs over a patients body restrain the market growth.

        The global Inflammatory Bowel Disease Therapeutics market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Inflammatory Bowel Disease Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Inflammatory Bowel Disease Therapeutics market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Inflammatory Bowel Disease Therapeutics in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Inflammatory Bowel Disease Therapeutics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Abbvie
        Johnson & Johnson
        GlaxoSmithKline
        Merck
        Novartis
        ...

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Anti-inflammatory Biologics
        Non-Steroidal Anti-inflammatory drugs (NSAIDs)
        Corticosteroids

        Segment by Application
        Solid
        Liquid

        Buy now